OTCPicks.com Stocks to Watch for Friday, September 26th EDIG, ANPI, PCOP
Dallas, TX 9/25/2008 11:22 PM GMT (TransWorldNews)
OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit
http://www.otcpicks.com
today to join this growing community.
Our Stocks to Watch tomorrow include e.Digital Corp. (OTCBB: EDIG), Angiotech Pharmaceuticals Inc. (NASDAQ: ANPI) and Pharmacopeia Corp. (Nasdaq: PCOP).
For the complete newsletter please visit:
http://www.otcpicks.com/daily-market-movers/index.php
For more in-depth coverage of small cap stocks visit
http://www.otcpicks.com
E DIGITAL CORPORATION (OTCBB: EDIG)
"Up 51.00% on Thursday"
e.Digital is a leading innovator of dedicated portable entertainment systems. e.Digital also owns and is pursuing the monetization of its Flash-R(TM) portfolio of flash memory-related patents. e.Digital was the first company to employ and patent important aspects of the use of removable flash memory in portable recording devices.
ANGIOTECH PHARMACEUTICALS INCORPORATED (NASDAQ: ANPI)
"Up 25.81% on Thursday"
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury.
PHARMACOPEIA INCORPORATED (NASDAQ: PCOP)
"Up 24.37% on Thursday"
Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical needs. The company has a broad portfolio of clinical and preclinical candidates under development internally or by partners including nine clinical compounds in Phase 2 or Phase 1 development addressing multiple indications including diabetic nephropathy, muscle wasting and inflammation. The company is leveraging its fully integrated drug discovery platform to sustain the growth of its development pipeline. Pharmacopeia has established strategic alliances with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough and Wyeth Pharmaceuticals.
About OTCPicks.com
OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at
publisher@otcpicks.com.
